Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting

Stopped early · Not applicable · Has a placebo group

Conditions studied: Chemotherapy-induced Nausea and Vomiting

In brief

This study evaluates the efficacy of auricular percutaneous electrical nerve field stimulator in children, adolescents and young adults with chemotherapy induced nausea and vomiting.

Key facts

Study ID

NCT05143554

Run by

Medical College of Wisconsin

People needed

18

Starts

2021-04-29

Expected to finish

2025-09-23

Last updated by the study team

2025-09-26

Who can join

Age: 4 and older, up to 30. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are scheduled to be admitted for chemotherapy administration and who will have at least one additional cycle of the same chemotherapy
• Chemotherapy regimens must include moderate and/or severe emetogenic chemotherapy

You may not qualify if…

• Significant developmental delays that would prohibit participation
• Infection or severe dermatological condition of ear
• Uncontrolled or severe infection
• No implanted electrical device is permitted
• Pregnancy
• Severe cardiopulmonary disease
• Diagnosis of hemophilia or other bleeding disorders
• Diagnosis psoriasis vulgaris

Where it is running

• Children's Wisconsin Hospital — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.